Scott R. Pancoast

Scott R. Pancoast

Founder at Zylö Therapeutic, Inc.

58 year
Health Technology
Consumer Services
Distribution Services

Profile

Scott R.
Pancoast
has founded Zylö Therapeutic, Inc. in 2017, where he currently serves as the Chief Executive Officer & Director.
He previously held the position of President, Chief Executive Officer & Director at Lpath, Inc. from 2011 to 2014.
He also served as Chairman at Vaxiion Therapeutics, Inc. and Director at iVOW, Inc., Western States Investment Corp., DermTech Operations, Inc., MPEX Pharmaceuticals, Inc., and Sound Health Solutions, Inc. Additionally, he was the President of Rutledge Investment Group LLC from 2014 to 2017.
Mr. Pancoast's education includes an undergraduate degree from the University of Virginia and an MBA from Harvard Business School.

Scott R. Pancoast active positions

CompaniesPositionStart
Founder 2017-10-31
All active positions of Scott R. Pancoast

Former positions of Scott R. Pancoast

CompaniesPositionEnd
DERMTECH, INC. Director/Board Member 2021-06-29
Director/Board Member 2019-07-31
Rutledge Investment Group LLC President 2017-09-30
Chief Executive Officer 2014-11-02
Director/Board Member 2007-10-28
See the detail of Scott R. Pancoast's experience

Training of Scott R. Pancoast

University of Virginia Undergraduate Degree
Harvard Business School Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Scott R. Pancoast's experience

Connections

56

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
DERMTECH, INC.

Health Technology

Private companies10

Distribution Services

Health Services

Finance

Health Technology

Health Technology

Commercial Services

Consumer Services

Health Technology

Health Technology

Rutledge Investment Group LLC

See company connections
  1. Stock Market
  2. Insiders
  3. Scott R. Pancoast